{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T06:20:22Z","timestamp":1792650022435,"version":"4.5.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,17]],"date-time":"2021-04-17T00:00:00Z","timestamp":1618617600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001791","name":"Griffith University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001791","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal for Parasitology: Drugs and Drug Resistance"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.ijpddr.2021.04.003","type":"journal-article","created":{"date-parts":[[2021,4,21]],"date-time":"2021-04-21T00:31:51Z","timestamp":1618965111000},"page":"17-22","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Antiplasmodial activity of the natural product compounds alstonine and himbeline"],"prefix":"10.1016","volume":"16","author":[{"given":"M.S.J.","family":"Arnold","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.R.","family":"Macdonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.J.","family":"Quinn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7011-3850","authenticated-orcid":false,"given":"T.S.","family":"Skinner-Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1591-8979","authenticated-orcid":false,"given":"K.T.","family":"Andrews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.M.","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpddr.2021.04.003_bib1","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/1475-2875-10-144","article-title":"Quinine, an old anti-malarial drug in a modern world: role in the treatment of malaria","volume":"10","author":"Achan","year":"2011","journal-title":"Malar. J."},{"key":"10.1016\/j.ijpddr.2021.04.003_bib2","doi-asserted-by":"crossref","first-page":"587160","DOI":"10.5402\/2012\/587160","article-title":"A review of the ethnobotany and pharmacological importance of Alstonia boonei de wild (Apocynaceae)","volume":"2012","author":"Adotey","year":"2012","journal-title":"ISRN Pharmacol"},{"issue":"22","key":"10.1016\/j.ijpddr.2021.04.003_bib3","doi-asserted-by":"crossref","first-page":"6114","DOI":"10.1016\/j.bmcl.2013.09.015","article-title":"Antimalarial activity of compounds comprising a primary benzene sulfonamide fragment","volume":"23","author":"Andrews","year":"2013","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"7","key":"10.1016\/j.ijpddr.2021.04.003_bib4","doi-asserted-by":"crossref","first-page":"4361","DOI":"10.1128\/AAC.02948-15","article-title":"Adaptation of the [3H]hypoxanthine uptake assay for in vitro-cultured Plasmodium knowlesi malaria parasites","volume":"60","author":"Arnold","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"10.1016\/j.ijpddr.2021.04.003_bib5","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0014-4894(86)90008-1","article-title":"Plasmodium falciparum: induction, selection, and characterization of pyrimethamine-resistant mutants","volume":"62","author":"Banyal","year":"1986","journal-title":"Exp. Parasitol."},{"issue":"1","key":"10.1016\/j.ijpddr.2021.04.003_bib6","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s12936-017-1787-y","article-title":"World Malaria Report: time to acknowledge Plasmodium knowlesi malaria","volume":"16","author":"Barber","year":"2017","journal-title":"Malar. J."},{"issue":"7","key":"10.1016\/j.ijpddr.2021.04.003_bib7","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.ijpara.2006.12.010","article-title":"Delayed parasite elimination in human infections treated with clindamycin parallels 'delayed death' of Plasmodium falciparum in vitro","volume":"37","author":"Burkhardt","year":"2007","journal-title":"Int. J. Parasitol."},{"issue":"1","key":"10.1016\/j.ijpddr.2021.04.003_bib8","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12936-016-1675-x","article-title":"New developments in anti-malarial target candidate and product profiles","volume":"16","author":"Burrows","year":"2017","journal-title":"Malar. J."},{"issue":"3","key":"10.1016\/j.ijpddr.2021.04.003_bib9","doi-asserted-by":"crossref","first-page":"201","DOI":"10.2174\/1386207317666140109120515","article-title":"Nature bank and the queensland compound library: unique international resources at the eskitis Institute for drug discovery","volume":"17","author":"Camp","year":"2014","journal-title":"Comb. Chem. High Throughput Screen."},{"issue":"6","key":"10.1016\/j.ijpddr.2021.04.003_bib10","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1021\/jo981983+","article-title":"Total synthesis of (+)-Himbacine and (+)-Himbeline","volume":"64","author":"Chackalamannil","year":"1999","journal-title":"J. Org. Chem."},{"issue":"11","key":"10.1016\/j.ijpddr.2021.04.003_bib11","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1021\/jm800180e","article-title":"Discovery of a novel, orally active himbacine-based thrombin receptor antagonist (SCH 530348) with potent antiplatelet activity","volume":"51","author":"Chackalamannil","year":"2008","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijpddr.2021.04.003_bib12","doi-asserted-by":"crossref","unstructured":"Craig, A. G., G. E. Grau, C. Janse, J. W. Kazura, D. Milner, J. W. Barnwell, G. Turner, J. Langhorne and M. participants of the Hinxton Retreat meeting on Animal Models for Research on Severe (2012). \"The role of animal models for research on severe malaria.\" PLoS Pathog. 8(2): e1002401.","DOI":"10.1371\/journal.ppat.1002401"},{"issue":"6469","key":"10.1016\/j.ijpddr.2021.04.003_bib13","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1126\/science.366.6469.1062","article-title":"A shot of hope","volume":"366","author":"de Vrieze","year":"2019","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.ijpddr.2021.04.003_bib14","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/ecam\/nek011","article-title":"The alkaloid alstonine: a review of its pharmacological properties","volume":"3","author":"Elisabetsky","year":"2006","journal-title":"Evid Based Complement Alternat Med"},{"issue":"3","key":"10.1016\/j.ijpddr.2021.04.003_bib15","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ijpddr.2015.05.004","article-title":"Profiling the anti-protozoal activity of anti-cancer HDAC inhibitors against Plasmodium and Trypanosoma parasites","volume":"5","author":"Engel","year":"2015","journal-title":"Int J Parasitol Drugs Drug Resist"},{"issue":"4","key":"10.1016\/j.ijpddr.2021.04.003_bib16","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/cbdd.12335","article-title":"Synthesis and evaluation of antimalarial properties of novel 4-aminoquinoline hybrid compounds","volume":"84","author":"Fisher","year":"2014","journal-title":"Chem. Biol. Drug Des."},{"issue":"1","key":"10.1016\/j.ijpddr.2021.04.003_bib17","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s40268-016-0158-4","article-title":"Vorapaxar: the current role and future directions of a novel protease-activated receptor antagonist for risk reduction in atherosclerotic disease","volume":"17","author":"Gryka","year":"2017","journal-title":"Drugs R"},{"issue":"7414","key":"10.1016\/j.ijpddr.2021.04.003_bib18","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0140-6736(65)90395-8","article-title":"Chloroquine-resistant falciparum malaria in Thailand","volume":"2","author":"Harinasuta","year":"1965","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.ijpddr.2021.04.003_bib19","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0001-706X(93)90083-N","article-title":"A comparison of three methods of estimating EC50 in studies of drug resistance of malaria parasites","volume":"55","author":"Huber","year":"1993","journal-title":"Acta Trop."},{"issue":"3","key":"10.1016\/j.ijpddr.2021.04.003_bib20","doi-asserted-by":"crossref","first-page":"523","DOI":"10.4269\/ajtmh.1981.30.523","article-title":"Clinical drug-resistant falciparum malaria acquired from cultured parasites","volume":"30","author":"Jensen","year":"1981","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"4703","key":"10.1016\/j.ijpddr.2021.04.003_bib21","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1126\/science.3887571","article-title":"Qinghaosu (artemisinin): an antimalarial drug from China","volume":"228","author":"Klayman","year":"1985","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.ijpddr.2021.04.003_bib22","doi-asserted-by":"crossref","first-page":"418","DOI":"10.2307\/3280287","article-title":"Synchronization of Plasmodium falciparum erythrocytic stages in culture","volume":"65","author":"Lambros","year":"1979","journal-title":"J. Parasitol."},{"issue":"1","key":"10.1016\/j.ijpddr.2021.04.003_bib23","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.pnpbp.2011.08.022","article-title":"5-HT2A\/C receptors mediate the antipsychotic-like effects of alstonine","volume":"36","author":"Linck","year":"2012","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.ijpddr.2021.04.003_bib24","doi-asserted-by":"crossref","first-page":"418597","DOI":"10.1093\/ecam\/nep002","article-title":"Alstonine as an antipsychotic: effects on brain amines and metabolic changes","author":"Linck","year":"2011","journal-title":"Evid Based Complement Alternat Med"},{"issue":"3","key":"10.1016\/j.ijpddr.2021.04.003_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0001889","article-title":"Genome-wide detection of serpentine receptor-like proteins in malaria parasites","volume":"3","author":"Madeira","year":"2008","journal-title":"PloS One"},{"key":"10.1016\/j.ijpddr.2021.04.003_bib26","author":"Mmv"},{"issue":"2","key":"10.1016\/j.ijpddr.2021.04.003_bib27","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1073\/pnas.1216457110","article-title":"Adaptation of the genetically tractable malaria pathogen Plasmodium knowlesi to continuous culture in human erythrocytes","volume":"110","author":"Moon","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4348","key":"10.1016\/j.ijpddr.2021.04.003_bib28","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1126\/science.351801","article-title":"Chloroquine resistance produced in vitro in an African strain of human malaria","volume":"200","author":"Nguyen-Dinh","year":"1978","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.ijpddr.2021.04.003_bib29","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1128\/AAC.46.8.2518-2524.2002","article-title":"Assessment of azithromycin in combination with other antimalarial drugs against Plasmodium falciparum in vitro","volume":"46","author":"Ohrt","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"issue":"5","key":"10.1016\/j.ijpddr.2021.04.003_bib30","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1081\/JLC-200048915","article-title":"Preparative separation of indole alkaloids from the rind of picralima nitida (stapf) T. Durand & H. Durand by pH\u2010zone\u2010refining countercurrent chromatography","volume":"28","author":"Okunji","year":"2005","journal-title":"J. Liq. Chromatogr. Relat. Technol."},{"issue":"1","key":"10.1016\/j.ijpddr.2021.04.003_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0378-8741(83)90028-4","article-title":"Medicinal plants in tropical West Africa. III. Anti-infection therapy with higher plants","volume":"9","author":"Oliver-Bever","year":"1983","journal-title":"J. Ethnopharmacol."},{"issue":"2","key":"10.1016\/j.ijpddr.2021.04.003_bib32","article-title":"Amodiaquine for treating malaria","author":"Olliaro","year":"2003","journal-title":"Cochrane Database Syst. Rev."},{"issue":"7131","key":"10.1016\/j.ijpddr.2021.04.003_bib33","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/nature05572","article-title":"Specific role of mitochondrial electron transport in blood-stage Plasmodium falciparum","volume":"446","author":"Painter","year":"2007","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.ijpddr.2021.04.003_bib34","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S1471-4922(01)02153-5","article-title":"DNA microarrays for malaria","volume":"18","author":"Rathod","year":"2002","journal-title":"Trends Parasitol."},{"issue":"8","key":"10.1016\/j.ijpddr.2021.04.003_bib35","doi-asserted-by":"crossref","DOI":"10.3390\/biom10081197","article-title":"Plasmodium falciparum knockout for the GPCR-like PfSR25 receptor displays greater susceptibility to 1,2,3-triazole compounds that block malaria parasite development","volume":"10","author":"Santos","year":"2020","journal-title":"Biomolecules"},{"issue":"2","key":"10.1016\/j.ijpddr.2021.04.003_bib36","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1708-8305.1999.tb00843.x","article-title":"Mefloquine for malaria chemoprophylaxis 1992-1998: a review","volume":"6","author":"Schlagenhauf","year":"1999","journal-title":"J. Trav. Med."},{"key":"10.1016\/j.ijpddr.2021.04.003_bib37","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/s42003-019-0397-3","article-title":"Cyclization-blocked proguanil as a strategy to improve the antimalarial activity of atovaquone","volume":"2","author":"Skinner-Adams","year":"2019","journal-title":"Commun Biol"},{"issue":"5","key":"10.1016\/j.ijpddr.2021.04.003_bib38","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.drudis.2016.01.002","article-title":"Defining the targets of antiparasitic compounds","volume":"21","author":"Skinner-Adams","year":"2016","journal-title":"Drug Discov. Today"},{"issue":"2\u20133","key":"10.1016\/j.ijpddr.2021.04.003_bib39","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0163-7258(93)90056-J","article-title":"Chloroquine: mechanism of drug action and resistance in Plasmodium falciparum","volume":"57","author":"Slater","year":"1993","journal-title":"Pharmacol. Ther."},{"issue":"7","key":"10.1016\/j.ijpddr.2021.04.003_bib40","doi-asserted-by":"crossref","first-page":"3961","DOI":"10.1074\/jbc.272.7.3961","article-title":"Atovaquone, a broad spectrum antiparasitic drug, collapses mitochondrial membrane potential in a malarial parasite","volume":"272","author":"Srivastava","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijpddr.2021.04.003_bib41","doi-asserted-by":"crossref","first-page":"34","DOI":"10.12688\/wellcomeopenres.15602.3","article-title":"Testing the effect of PAR1 inhibitors on Plasmodium falciparum-induced loss of endothelial cell barrier function","volume":"5","author":"Storm","year":"2020","journal-title":"Wellcome Open Res"},{"issue":"4254","key":"10.1016\/j.ijpddr.2021.04.003_bib42","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1126\/science.781840","article-title":"Human malaria parasites in continuous culture","volume":"193","author":"Trager","year":"1976","journal-title":"Science"},{"key":"10.1016\/j.ijpddr.2021.04.003_bib43","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ijpddr.2019.02.004","article-title":"Plasmodium knowlesi exhibits distinct in vitro drug susceptibility profiles from those of Plasmodium falciparum","volume":"9","author":"van Schalkwyk","year":"2019","journal-title":"Int J Parasitol Drugs Drug Resist"},{"issue":"4809","key":"10.1016\/j.ijpddr.2021.04.003_bib44","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1126\/science.3299700","article-title":"Genetic analysis of the human malaria parasite Plasmodium falciparum","volume":"236","author":"Walliker","year":"1987","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.ijpddr.2021.04.003_bib45","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1046\/j.1365-2958.1997.2821646.x","article-title":"Sulfadoxine resistance in the human malaria parasite Plasmodium falciparum is determined by mutations in dihydropteroate synthetase and an additional factor associated with folate utilization","volume":"23","author":"Wang","year":"1997","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.ijpddr.2021.04.003_bib46","series-title":"World Malaria Report","author":"WHO","year":"2020"},{"issue":"7","key":"10.1016\/j.ijpddr.2021.04.003_bib47","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1021\/np9602325","article-title":"Antimalarial activity: the search for marine-derived natural products with selective antimalarial activity","volume":"59","author":"Wright","year":"1996","journal-title":"J. Nat. Prod."},{"issue":"1","key":"10.1016\/j.ijpddr.2021.04.003_bib48","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1128\/AAC.03342-14","article-title":"A chemical rescue screen identifies a Plasmodium falciparum apicoplast inhibitor targeting MEP isoprenoid precursor biosynthesis","volume":"59","author":"Wu","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"issue":"8","key":"10.1016\/j.ijpddr.2021.04.003_bib49","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1001138","article-title":"Chemical rescue of malaria parasites lacking an apicoplast defines organelle function in blood-stage Plasmodium falciparum","volume":"9","author":"Yeh","year":"2011","journal-title":"PLoS Biol."},{"issue":"2","key":"10.1016\/j.ijpddr.2021.04.003_bib50","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/108705719900400206","article-title":"A simple statistical parameter for use in evaluation and validation of high throughput screening assays","volume":"4","author":"Zhang","year":"1999","journal-title":"J. Biomol. Screen"},{"issue":"6388","key":"10.1016\/j.ijpddr.2021.04.003_bib51","doi-asserted-by":"crossref","DOI":"10.1126\/science.aap7847","article-title":"Uncovering the essential genes of the human malaria parasite Plasmodium falciparum by saturation mutagenesis","volume":"360","author":"Zhang","year":"2018","journal-title":"Science"}],"container-title":["International Journal for Parasitology: Drugs and Drug Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211320721000178?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211320721000178?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:51:44Z","timestamp":1761922304000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211320721000178"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":51,"alternative-id":["S2211320721000178"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpddr.2021.04.003","relation":{},"ISSN":["2211-3207"],"issn-type":[{"value":"2211-3207","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antiplasmodial activity of the natural product compounds alstonine and himbeline","name":"articletitle","label":"Article Title"},{"value":"International Journal for Parasitology: Drugs and Drug Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpddr.2021.04.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Ltd on behalf of Australian Society for Parasitology.","name":"copyright","label":"Copyright"}]}}